Flora Growth Corp. (FLGC)

USD 0.46

(0.65%)

Long Term Debt Summary of Flora Growth Corp.

  • Flora Growth Corp.'s latest annual long term debt in 2023 was 942 Thousand USD , down -49.6% from previous year.
  • Flora Growth Corp.'s latest quarterly long term debt in 2024 Q2 was 2.39 Million USD , down 0.0% from previous quarter.
  • Flora Growth Corp. reported annual long term debt of 1.86 Million USD in 2022, up 105.84% from previous year.
  • Flora Growth Corp. reported annual long term debt of 908 Thousand USD in 2021, up 183.75% from previous year.
  • Flora Growth Corp. reported quarterly long term debt of 2.39 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Flora Growth Corp. reported quarterly long term debt of 942 Thousand USD for 2023 FY, down -49.6% from previous quarter.

Annual Long Term Debt Chart of Flora Growth Corp. (2023 - 2019)

Historical Annual Long Term Debt of Flora Growth Corp. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 942 Thousand USD -49.6%
2022 1.86 Million USD 105.84%
2021 908 Thousand USD 183.75%
2020 320 Thousand USD 30.19%
2019 245.8 Thousand USD 0.0%

Peer Long Term Debt Comparison of Flora Growth Corp.

Name Long Term Debt Long Term Debt Difference
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.696%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.808%
Dynavax Technologies Corporation 252.41 Million USD 99.627%
Embecta Corp. 1.62 Billion USD 99.942%
Esperion Therapeutics, Inc. 501.54 Million USD 99.812%
Aquestive Therapeutics, Inc. 91.07 Million USD 98.966%
Cosmos Health Inc. 3.03 Million USD 68.966%
Pacira BioSciences, Inc. 513.79 Million USD 99.817%
Journey Medical Corporation 14.62 Million USD 93.558%
PainReform Ltd. 30 Thousand USD -3040.0%
Sunshine Biopharma, Inc. 539.03 Thousand USD -74.757%
Sunshine Biopharma, Inc. 539.03 Thousand USD -74.757%
SCYNEXIS, Inc. 12.15 Million USD 92.253%
Safety Shot Inc 304.9 Thousand USD -208.947%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -704.241%
Alpha Teknova, Inc. 13.25 Million USD 92.891%
Intra-Cellular Therapies, Inc. 13.32 Million USD 92.931%
Bright Green Corporation 201.78 Thousand USD -366.838%
Procaps Group, S.A. 28.41 Million USD 96.684%
Theratechnologies Inc. 51.26 Million USD 98.162%
Harrow Health, Inc. 183.17 Million USD 99.486%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -982.759%
Biofrontera Inc. 804 Thousand USD -17.164%
DURECT Corporation 2.7 Million USD 65.137%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 97.162%
Cronos Group Inc. 1.55 Million USD 39.577%
OptiNose, Inc. 611 Thousand USD -54.173%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.811%
Kala Pharmaceuticals, Inc. 34.19 Million USD 97.245%
RedHill Biopharma Ltd. 455 Thousand USD -107.033%
Organogenesis Holdings Inc. 60.74 Million USD 98.449%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 92.631%
Radius Health, Inc. 339.66 Million USD 99.723%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD 90.817%
Phibro Animal Health Corporation 458.28 Million USD 99.794%
Procaps Group S.A. 28.41 Million USD 96.684%
Alvotech 1.02 Billion USD 99.908%
TherapeuticsMD, Inc. 6.53 Million USD 85.579%
Viatris Inc. 16.18 Billion USD 99.994%
Rockwell Medical, Inc. 8.29 Million USD 88.641%
Aytu BioPharma, Inc. 10.87 Million USD 91.34%
SIGA Technologies, Inc. 335.99 Thousand USD -180.365%
Tilray Brands, Inc. 287.93 Million USD 99.673%
Lifecore Biomedical, Inc. 120.51 Million USD 99.218%
Shineco, Inc. 10.01 Million USD 90.596%
PetIQ, Inc. 437.82 Million USD 99.785%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD -348.571%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.635%
Alimera Sciences, Inc. 64.48 Million USD 98.539%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD 97.554%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -597.318%
Petros Pharmaceuticals, Inc. 6.85 Million USD 86.263%
Clever Leaves Holdings Inc. 720 Thousand USD -30.833%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -4089.646%
Avadel Pharmaceuticals plc 32.75 Million USD 97.125%
Hempacco Co., Inc. 5.93 Million USD 84.117%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 99.908%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 98.324%
Lantheus Holdings, Inc. 616.12 Million USD 99.847%
Currenc Group, Inc. 2.5 Million USD 62.425%
Kamada Ltd. 7.43 Million USD 87.335%
Indivior PLC 235.66 Million USD 99.6%
Evoke Pharma, Inc. 5 Million USD 81.16%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -4089.646%
Evolus, Inc. 120.35 Million USD 99.217%
HUTCHMED (China) Limited 48.18 Million USD 98.045%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.84%
Akanda Corp. 2.49 Million USD 62.277%